Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shih Yea Sylvia Wu"'
Autor:
Seiichiro Abe, Shih Yea Sylvia Wu, Mai Ego, Hiroyuki Takamaru, Masau Sekiguchi, Masayoshi Yamada, Satoru Nonaka, Taku Sakamoto, Haruhisa Suzuki, Shigetaka Yoshinaga, Takahisa Matsuda, Ichiro Oda, Yutaka Saito
Publikováno v:
Gut and Liver, Vol 14, Iss 6, Pp 673-684 (2020)
This systematic review aimed to assess the efficacy of the current approach to tissue traction during the endoscopic submucosal dissection (ESD) of superficial esophageal cancer, early gastric cancer, and colorectal neoplasms. We performed a systemat
Externí odkaz:
https://doaj.org/article/a9abca697271403680cf1ab0def1b039
Autor:
Mai Ego, MD, Seiichiro Abe, MD, PhD, Shih Yea Sylvia Wu, MD, Ichiro Oda, MD, Yutaka Saito, MD, PhD
Publikováno v:
VideoGIE, Vol 5, Iss 5, Pp 193-195 (2020)
Externí odkaz:
https://doaj.org/article/d8b9cc6014814f83b95fb4cfdbc7da60
Publikováno v:
VideoGIE, Vol 4, Iss 7, Pp 314-318 (2019)
Externí odkaz:
https://doaj.org/article/ac1b3840a78d4150afcbcf1d9cba7c9e
Publikováno v:
Case Reports in Medicine, Vol 2017 (2017)
VIEKIRA PAK (ritonavir-boosted paritaprevir/ombitasvir and dasabuvir) is an approved treatment for compensated patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection. This oral regimen has minimal adverse effects and is well tolerat
Externí odkaz:
https://doaj.org/article/fddefcbefa5945158341a90b37ebadda
Publikováno v:
VideoGIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1626184392b8d8c18de94755bac1bdf7
http://europepmc.org/articles/PMC7221320
http://europepmc.org/articles/PMC7221320
Autor:
Ichiro Oda, Taku Sakamoto, Yutaka Saito, Takahisa Matsuda, Masayoshi Yamada, Mai Ego, Shih Yea Sylvia Wu, Shigetaka Yoshinaga, Masau Sekiguchi, Satoru Nonaka, Seiichiro Abe, Hiroyuki Takamaru, Haruhisa Suzuki
Publikováno v:
Gut and Liver
This systematic review aimed to assess the efficacy of the current approach to tissue traction during the endoscopic submucosal dissection (ESD) of superficial esophageal cancer, early gastric cancer, and colorectal neoplasms. We performed a systemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60dc63526a87cdeb6ea9083d73258c12
http://europepmc.org/articles/PMC7667936
http://europepmc.org/articles/PMC7667936
Publikováno v:
VideoGIE
To ensure safe and successful ESD, the essential preparation for colorectal ESD includes CO2 insufflation, therapeutic colonoscope with water-jet function, hyaluronic acid solution, and short-type ST hood. When both a Jet B-knife and an IT knife nano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c5766abe9be5f274723d170ee680d2
https://doi.org/10.1016/j.vgie.2019.04.019
https://doi.org/10.1016/j.vgie.2019.04.019
Autor:
Yohei, Koyama, Masayoshi, Yamada, Mai Ego, Makiguchi, Masau, Sekiguchi, Hiroyuki, Takamaru, Taku, Sakamoto, Shin, Kono, Masakatsu, Fukuzawa, Shih Yea, Sylvia Wu, Arjun, Sugumaran, Takashi, Kawai, Takahisa, Matsuda, Takao, Itoi, Yutaka, Saito
Publikováno v:
Gastrointestinal Endoscopy. 96:321-329.e2
Diagnostics to differentiate deep submucosal invasive (invasion depth ≥1000 μm [T1b]) colorectal cancer (CRC) from muscularis propria invasive (T2) CRC are limited. We aimed to establish and validate a scoring system that differentiates T1b from T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc973c3a3cf9b7b921bd60e656064784
https://doi.org/10.1016/j.gie.2022.03.002
https://doi.org/10.1016/j.gie.2022.03.002
Autor:
Yuta Maruki, Chigusa Morizane, Yutaka Saito, Takuji Okusaka, Yoshikuni Nagashio, Hideki Ueno, Susumu Hijioka, Shunsuke Kondo, Akihiro Ohba, Shih Yea Sylvia Wu
Publikováno v:
Gastrointestinal endoscopy. 92(3)
Three or more stents may be needed in patients with extensive stricturing in Bismuth type IIIa/IV hilar malignant strictures. Partial stent-in-stent (PSIS) deployment has been the primary intervention for hilar malignant biliary stricture (MBS). Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66eb24ca0252954d263824fc33c182b8
https://pubmed.ncbi.nlm.nih.gov/32169434
https://pubmed.ncbi.nlm.nih.gov/32169434
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2017 (2017)
Case Reports in Medicine, Vol 2017 (2017)
VIEKIRA PAK (ritonavir-boosted paritaprevir/ombitasvir and dasabuvir) is an approved treatment for compensated patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection. This oral regimen has minimal adverse effects and is well tolerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfd475d1c1916733d47398e239f943e3
https://doi.org/10.1155/2017/4895736
https://doi.org/10.1155/2017/4895736